A valid mouse model of AGRIN-associated congenital myasthenic syndrome

Human Molecular Genetics

Volumn 20, Issue 23, 2011, Pages 4617-4633

  Bogdanik, Laurent P ^a   Burgess, Robert W ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGRIN; CHOLINERGIC RECEPTOR; MUTANT PROTEIN; PHENYLALANINE; PROTEOGLYCAN; SERINE;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGENITAL MYASTHENIC SYNDROME; CONTROLLED STUDY; DENERVATION; DISEASE COURSE; DISEASE MODEL; DISEASE SEVERITY; ELECTRON MICROSCOPY; HOMOZYGOSITY; LOSS OF FUNCTION MUTATION; MALE; MOTOR NEURON DISEASE; MOUSE; MUSCLE ATROPHY; MUTAGENESIS; NEUROMUSCULAR JUNCTION DISORDER; NONHUMAN; POINT MUTATION; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION; RECEPTOR DENSITY; SENSITIVITY ANALYSIS; SYNAPSE; WILD TYPE;

AGRIN; ALLELES; AMINO ACID SEQUENCE; ANIMALS; ANIMALS, NEWBORN; BASE SEQUENCE; CELL MEMBRANE; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; GLYCOSYLATION; MICE; MITOCHONDRIA; MOLECULAR SEQUENCE DATA; MOTOR NEURON DISEASE; MUSCLE FIBERS, SKELETAL; MUTANT PROTEINS; MUTATION; MYASTHENIC SYNDROMES, CONGENITAL; NEUROMUSCULAR JUNCTION; PHENOTYPE; PROTEIN STABILITY; PROTEIN TRANSPORT; PROTEOLYSIS; REPRODUCIBILITY OF RESULTS;

MUS;

EID: 81255209222     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr396     Document Type: Article

References (69)

1. Engel, A.G., Ohno, K. and Sine, S.M. (2004) Chapter 66: Congenital Myasthenic Syndrome. In Engel, A.G. and Franzini-Armstrong, C. (eds), Myology. 3rd edn. McGraw-Hill, New York, Vol. 2, pp. 1801-1854.
2. Sanes, J.R. and Lichtman, J.W. (1999) Development of the vertebrate neuromuscular junction. Ann. Rev. Neurosci., 22, 389-442.
3. Burden, S.J. (2002) Building the vertebrate neuromuscular synapse. J. Neurobiol., 53, 501-511.
4. Kummer, T.T., Misgeld, T. and Sanes, J.R. (2006) Assembly of the postsynaptic membrane at the neuromuscular junction: paradigm lost. Curr. Opin. Neurobiol., 16, 74-82.
5. Nitkin, R.M., Smith, M.A., Magill, C., Fallon, J.R., Yao, Y.M., Wallace, B.G. and McMahan, U.J. (1987) Identification of agrin, a synaptic organizing protein from Torpedo electric organ. J. Cell Biol., 105, 2471-2478.
6. Cohen, I., Rimer, M., Lomo, T. and McMahan, U.J. (1997) Agrin-induced postsynaptic-like apparatus in skeletal muscle fibers in vivo. Mol. Cell Neurosci., 9, 237-253.
7. Ferns, M., Hoch, W., Campanelli, J.T., Rupp, F., Hall, Z.W. and Scheller, R.H. (1992) RNA splicing regulates agrin-mediated acetylcholine receptor clustering activity on cultured myotubes. Neuron, 8, 1079-1086.
8. Hoch, W., Ferns, M., Campanelli, J.T., Hall, Z.W. and Scheller, R.H. (1993) Developmental regulation of highly active alternatively spliced forms of agrin. Neuron, 11, 479-490.
9. Ferns, M.J., Campanelli, J.T., Hoch, W., Scheller, R.H. and Hall, Z. (1993) The ability of agrin to cluster AChRs depends on alternative splicing and on cell surface proteoglycans. Neuron, 11, 491-502.
10. Kim, N., Stiegler, A.L., Cameron, T.O., Hallock, P.T., Gomez, A.M., Huang, J.H., Hubbard, S.R., Dustin, M.L. and Burden, S.J. (2008) Lrp4 is a receptor for Agrin and forms a complex with MuSK. Cell, 135, 334-342.
11. Zhang, B., Luo, S., Wang, Q., Suzuki, T., Xiong, W.C. and Mei, L. (2008) LRP4 serves as a coreceptor of agrin. Neuron, 60, 285-297.
12. Glass, D.J., Bowen, D.C., Stitt, T.N., Radziejewski, C., Bruno, J., Ryan, T.E., Gies, D.R., Shah, S., Mattsson, K., Burden, S.J. et al. (1996) Agrin acts via a MuSK receptor complex. Cell, 85, 513-523.
13. Burgess, R.W., Dickman, D.K., Nunez, L., Glass, D.J. and Sanes, J.R. (2002) Mapping sites responsible for interactions of agrin with neurons. J. Neurochem., 83, 271-284.
14. Neumann, F.R., Bittcher, G., Annies, M., Schumacher, B., Kroger, S. and Ruegg, M.A. (2001) An alternative amino-terminus expressed in the central nervous system converts agrin to a type II transmembrane protein. Mol. Cell Neurosci., 17, 208-225.
15. Burgess, R.W., Skarnes, W.C. and Sanes, J.R. (2000) Agrin isoforms with distinct amino termini: differential expression, localization, and function. J. Cell Biol., 151, 41-52.
16. Lin, W., Burgess, R.W., Dominguez, B., Pfaff, S.L., Sanes, J.R. and Lee, K.F. (2001) Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse. Nature, 410, 1057-1064.
17. Gautam, M., Noakes, P.G., Moscoso, L., Rupp, F., Scheller, R.H., Merlie, J.P. and Sanes, J.R. (1996) Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell, 85, 525-535.
18. Burgess, R.W., Nguyen, Q.T., Son, Y.J., Lichtman, J.W. and Sanes, J.R. (1999) Alternatively spliced isoforms of nerve- and muscle-derived agrin: their roles at the neuromuscular junction. Neuron, 23, 33-44.
19. Weatherbee, S.D., Anderson, K.V. and Niswander, L.A. (2006) LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction. Development, 133, 4993-5000.
20. DeChiara, T.M., Bowen, D.C., Valenzuela, D.M., Simmons, M.V., Poueymirou, W.T., Thomas, S., Kinetz, E., Compton, D.L., Rojas, E., Park, J.S. et al. (1996) The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell, 85, 501-512.
21. Beeson, D., Higuchi, O., Palace, J., Cossins, J., Spearman, H., Maxwell, S., Newsom-Davis, J., Burke, G., Fawcett, P., Motomura, M. et al. (2006) Dok-7 mutations underlie a neuromuscular junction synaptopathy. Science, 313, 1975-1978.
22. Chevessier, F., Faraut, B., Ravel-Chapuis, A., Richard, P., Gaudon, K., Bauche, S., Prioleau, C., Herbst, R., Goillot, E., Ioos, C. et al. (2004) MUSK, a new target for mutations causing congenital myasthenic syndrome. Hum. Mol. Genet., 13, 3229-3240.
23. Ohno, K., Engel, A.G., Shen, X.M., Selcen, D., Brengman, J., Harper, C.M., Tsujino, A. and Milone, M. (2002) Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome. Am. J. Hum. Genet., 70, 875-885.
24. Hoch, W., McConville, J., Helms, S., Newsom-Davis, J., Melms, A. and Vincent, A. (2001) Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat. Med., 7, 365-368.
25. Huze, C., Bauche, S., Richard, P., Chevessier, F., Goillot, E., Gaudon, K., Ben Ammar, A., Chaboud, A., Grosjean, I., Lecuyer, H.A. et al. (2009) Identification of an agrin mutation that causes congenital myasthenia and affects synapse function. Am. J. Hum. Genet., 85, 155-167.
26. Harvey, S.J., Jarad, G., Cunningham, J., Rops, A.L., van der Vlag, J., Berden, J.H., Moeller, M.J., Holzman, L.B., Burgess, R.W. and Miner, J.H. (2007) Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity. Am. J. Pathol., 171, 139-152.
27. Seburn, K.L., Nangle, L.A., Cox, G.A., Schimmel, P. and Burgess, R.W. (2006) An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model. Neuron, 51, 715-726.
28. Patton, B.L., Wang, B., Tarumi, Y.S., Seburn, K.L. and Burgess, R.W. (2008) A single point mutation in the LN domain of LAMA2 causes muscular dystrophy and peripheral amyelination. J. Cell Sci., 121, 1593-1604.
29. Achilli, F., Bros-Facer, V., Williams, H.P., Banks, G.T., AlQatari, M., Chia, R., Tucci, V., Groves, M., Nickols, C.D., Seburn, K.L. et al. (2009) An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy. Dis. Model Mech., 2, 359-373.
30. Fuerst, P.G., Rauch, S.M. and Burgess, R.W. (2007) Defects in eye development in transgenic mice overexpressing the heparan sulfate proteoglycan agrin. Dev. Biol., 303, 165-180.
31. Bork, P. and Patthy, L. (1995) The SEA module: a new extracellular domain associated with O-glycosylation. Prot. Sci., 4, 1421-1425.
32. Maeda, T., Inoue, M., Koshiba, S., Yabuki, T., Aoki, M., Nunokawa, E., Seki, E., Matsuda, T., Motoda, Y., Kobayashi, A. et al. (2004) Solution structure of the SEA domain from the murine homologue of ovarian cancer antigen CA125 (MUC16). J. Biol. Chem., 279, 13174-13182.
33. Feng, G., Mellor, R.H., Bernstein, M., Keller-Peck, C., Nguyen, Q.T., Wallace, M., Nerbonne, J.M., Lichtman, J.W. and Sanes, J.R. (2000) Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron, 28, 41-51.
34. Khanna, S., Richmonds, C.R., Kaminski, H.J. and Porter, J.D. (2003) Molecular organization of the extraocular muscle neuromuscular junction: partial conservation of and divergence from the skeletal muscle prototype. Invest. Ophth. Vis. Sci., 44, 1918-1926.
35. Gatesy, S.M. and English, A.W. (1993) Evidence for compartmental identity in the development of the rat lateral gastrocnemius muscle. Dev. Dyn., 196, 174-182.
36. Saxena, S., Cabuy, E. and Caroni, P. (2009) A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat. Neurosci., 12, 627-636.
37. Pun, S., Santos, A.F., Saxena, S., Xu, L. and Caroni, P. (2006) Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat. Neurosci., 9, 408-419.
38. Fischer, L.R., Culver, D.G., Tennant, P., Davis, A.A., Wang, M., Castellano-Sanchez, A., Khan, J., Polak, M.A. and Glass, J.D. (2004) Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol., 185, 232-240.
39. Kariya, S., Park, G.H., Maeno-Hikichi, Y., Leykekhman, O., Lutz, C., Arkovitz, M.S., Landmesser, L.T. and Monani, U.R. (2008) Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum. Mol. Genet., 17, 2552-2569.
40. Raats, C.J., Bakker, M.A., Hoch, W., Tamboer, W.P., Groffen, A.J., van den Heuvel, L.P., Berden, J.H. and van den Born, J. (1998) Differential expression of agrin in renal basement membranes as revealed by domain-specific antibodies. J. Biol. Chem., 273, 17832-17838.
41. Reif, R., Sales, S., Hettwer, S., Dreier, B., Gisler, C., Wolfel, J., Luscher, D., Zurlinden, A., Stephan, A., Ahmed, S. et al. (2007) Specific cleavage of agrin by neurotrypsin, a synaptic protease linked to mental retardation. FASEB J., 21, 3468-3478.
42. Stephan, A., Mateos, J.M., Kozlov, S.V., Cinelli, P., Kistler, A.D., Hettwer, S., Rulicke, T., Streit, P., Kunz, B. and Sonderegger, P. (2008) Neurotrypsin cleaves agrin locally at the synapse. FASEB J., 22, 1861-1873.
43. Bolliger, M.F., Zurlinden, A., Luscher, D., Butikofer, L., Shakhova, O., Francolini, M., Kozlov, S.V., Cinelli, P., Stephan, A., Kistler, A.D. et al. (2010) Specific proteolytic cleavage of agrin regulates maturation of the neuromuscular junction. J. Cell Sci., 123, 3944-3955.
44. Gautam, M., Noakes, P.G., Mudd, J., Nichol, M., Chu, G., Sanes, J.A. and Merlie, J. (1995) Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice. Nature, 377, 232-236.
45. Okada, K., Inoue, A., Okada, M., Murata, Y., Kakuta, S., Jigami, T., Kubo, S., Shiraishi, H., Eguchi, K., Motomura, M. et al. (2006) The muscle protein Dok-7 is essential for neuromuscular synaptogenesis. Science, 312, 1802-1805.
46. Gesemann, M., Denzer, A.J. and Ruegg, M.A. (1995) Acetylcholine receptor-aggregating activity of agrin isoforms and mapping of the active site. J. Cell Biol., 128, 625-636.
47. Ksiazek, I., Burkhardt, C., Lin, S., Seddik, R., Maj, M., Bezakova, G., Jucker, M., Arber, S., Caroni, P., Sanes, J.R. et al. (2007) Synapse loss in cortex of agrin-deficient mice after genetic rescue of perinatal death. J. Neurosci., 27, 7183-7195.
48. Akhavan, A., Crivelli, S.N., Singh, M., Lingappa, V.R. and Muschler, J.L. (2008) SEA domain proteolysis determines the functional composition of dystroglycan. FASEB J., 22, 612-621.
49. Palmai-Pallag, T., Khodabukus, N., Kinarsky, L., Leir, S.H., Sherman, S., Hollingsworth, M.A. and Harris, A. (2005) The role of the SEA (sea urchin sperm protein, enterokinase and agrin) module in cleavage of membrane-tethered mucins. FEBS J., 272, 2901-2911.
50. Levitin, F., Stern, O., Weiss, M., Gil-Henn, C., Ziv, R., Prokocimer, Z., Smorodinsky, N.I., Rubinstein, D.B. and Wreschner, D.H. (2005) The MUC1 SEA module is a self-cleaving domain. J. Biol. Chem., 280, 33374-33386.
51. Macao, B., Johansson, D.G., Hansson, G.C. and Hard, T. (2006) Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin. Nat. Struct. Mol. Biol., 13, 71-76.
52. Dolan, M., Horchar, T., Rigatti, B. and Hassell, J.R. (1997) Identification of sites in domain I of perlecan that regulate heparan sulfate synthesis. J. Biol. Chem., 272, 4316-4322.
53. VanSaun, M. and Werle, M.J. (2000) Matrix metalloproteinase-3 removes agrin from synaptic basal lamina. J. Neurobiol., 43, 140-149.
54. VanSaun, M., Herrera, A.A. and Werle, M.J. (2003) Structural alterations at the neuromuscular junctions of matrix metalloproteinase 3 null mutant mice. J. Neurocytol., 32, 1129-1142.
55. Werle, M.J. and VanSaun, M. (2003) Activity dependent removal of agrin from synaptic basal lamina by matrix metalloproteinase 3. J. Neurocytol., 32, 905-913.
56. Xia, B. and Martin, P.T. (2002) Modulation of agrin binding and activity by the CT and related carbohydrate antigens. Mol. Cell Neurosci., 19, 539-551.
57. Burgess, R.W., Cox, G.A. and Seburn, K.L. (2010) Neuromuscular disease models and analysis. Methods Mol. Biol., 602, 347-393.
58. Eusebio, A., Oliveri, F., Barzaghi, P. and Ruegg, M.A. (2003) Expression of mouse agrin in normal, denervated and dystrophic muscle. Neuromuscul. Disord., 13, 408-415.
59. Enomoto, H., Araki, T., Jackman, A., Heuckeroth, R.O., Snider, W.D., Johnson, E.M. Jr and Milbrandt, J. (1998) GFR alpha1-deficient mice have deficits in the enteric nervous system and kidneys. Neuron, 21, 317-324.
60. Hongyo, T., Buzard, G.S., Calvert, R.J. and Weghorst, C.M. (1993) 'Cold SSCP': a simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses. Nucleic Acids Res., 21, 3637-3642.
61. Xie, T., Ho, S.L. and Ma, O.C. (1997) High resolution single strand conformation polymorphism analysis using formamide and ethidium bromide staining. Mol. Pathol., 50, 276-278.
62. Kislinger, T., Cox, B., Kannan, A., Chung, C., Hu, P., Ignatchenko, A., Scott, M.S., Gramolini, A.O., Morris, Q., Hallett, M.T. et al. (2006) Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling. Cell, 125, 173-186.
63. Lin, L., McCroskery, S., Ross, J.M., Chak, Y., Neuhuber, B. and Daniels, M.P. (2010) Induction of filopodia-like protrusions by transmembrane agrin: role of agrin glycosaminoglycan chains and Rho-family GTPases. Exp. Cell Res., 316, 2260-2277.
64. Flanagan, J.G., Cheng, H.J., Feldheim, D.A., Hattori, M., Lu, Q. and Vanderhaeghen, P. (2000) Alkaline phosphatase fusions of ligands or receptors as in situ probes for staining of cells, tissues, and embryos. Methods Enzymol., 327, 19-35.
65. Misgeld, T., Kerschensteiner, M., Bareyre, F.M., Burgess, R.W. and Lichtman, J.W. (2007) Imaging axonal transport of mitochondria in vivo. Nat. Methods, 4, 559-561.
66. Finn, R.D., Mistry, J., Tate, J., Coggill, P., Heger, A., Pollington, J.E., Gavin, O.L., Gunasekaran, P., Ceric, G., Forslund, K. et al. (2009) The Pfam protein families database. Nucleic Acids Res., 38, D211-D222.
67. Waterhouse, A.M., Procter, J.B., Martin, D.M., Clamp, M. and Barton, G.J. (2009) Jalview Version 2-a multiple sequence alignment editor and analysis workbench. Bioinformatics, 25, 1189-1191.
68. Moreland, J.L., Gramada, A., Buzko, O.V., Zhang, Q. and Bourne, P.E. (2005) The Molecular Biology Toolkit (MBT): a modular platform for developing molecular visualization applications. BMC Bioinformatics, 6, 21.
69. Cole, C., Barber, J.D. and Barton, G.J. (2008) The Jpred 3 secondary structure prediction server. Nucleic Acids Res., 36, W197-W201.